2,855
edits
Psychedelic Therapy Inclusion and Exclusion Criteria: Difference between revisions
Psychedelic Therapy Inclusion and Exclusion Criteria (view source)
Revision as of 01:55, 16 October 2023
, 01:55, 16 October 2023no edit summary
mNo edit summary |
mNo edit summary |
||
| Line 57: | Line 57: | ||
9. Any other clinically significant cardiovascular, pulmonary, gastrointestinal, hepatic, renal or any other major concurrent illness that, in the opinion of the investigator, may have interfered with the interpretation of the study results or constitute a health risk for the participant if he/she took part in the study. | 9. Any other clinically significant cardiovascular, pulmonary, gastrointestinal, hepatic, renal or any other major concurrent illness that, in the opinion of the investigator, may have interfered with the interpretation of the study results or constitute a health risk for the participant if he/she took part in the study. | ||
== Adverse Effects == | |||
All medicines taken without proper guidance can result in adverse effects. Psychedelics are not immune to this distinction, if in doubt check potential [[Adverse Psychedelic Effects|adverse effects to psychedelics]] for more information. | |||
'''Reference''' | '''Reference''' | ||